PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23049663-8	2012	National treatment guidelines have largely been met with 83% patients with CD4 <350 cells/mm(3) receiving ARV.	omega-N-Allylarginine	109-112	CD4 molecule	Homo sapiens	75-78	
29927129-8	2015	The serologic profile was dominated by HIV1 (97.09%) with a number of average CD4 of 210.99 cells/mm3 at the initiation of the ARV treatment.	omega-N-Allylarginine	127-130	CD4 molecule	Homo sapiens	78-81	
18395383-9	2008	Under ARV, the median CD4 count was 478cells per millimetre cube (1 to 2166) and 84.8% of patients had an undetectable viral load (VL).	omega-N-Allylarginine	6-9	CD4 molecule	Homo sapiens	22-25	
14565611-7	2003	In the non-DAI-non-ARV-treated group, 86% could have qualified for ARV treatment according to the DAI medical criteria (CD4 cell counts < 500 x 10(6) cells/l), and only 32.9% of those medically eligible were prescribed cotrimoxazole prophylaxis.	omega-N-Allylarginine	19-22	CD4 molecule	Homo sapiens	120-123	
20182359-2	2010	We hypothesized that measuring naive CD4 cells in blood in people at earlier stages of disease would identify those at highest risk for poor CD4 reconstitution who may benefit from earlier initiation of ARV.	omega-N-Allylarginine	203-206	CD4 molecule	Homo sapiens	37-40	
20182359-2	2010	We hypothesized that measuring naive CD4 cells in blood in people at earlier stages of disease would identify those at highest risk for poor CD4 reconstitution who may benefit from earlier initiation of ARV.	omega-N-Allylarginine	203-206	CD4 molecule	Homo sapiens	141-144	
19431223-11	2009	Colonized patients typically underwent salvage therapy (p 0.003), and had more episodes of opportunistic fungal infections (p 0.046) and malignancies (p 0.004).Oral Candida colonization in patients under ARV therapy was associated with the immunosupressed status of HIV-infected patients, i.e. low number of CD4(+) T-cells per cubic millimetre, failure of ARV therapy (salvage therapy), and higher number of opportunistic infections and malignancies.	omega-N-Allylarginine	204-207	CD4 molecule	Homo sapiens	308-311	
31762906-13	2019	There was a positive correlation (rs=+0.4; p=0.01) in ARV treated children between CD4 count and FasL concentration.	omega-N-Allylarginine	54-57	CD4 molecule	Homo sapiens	83-86